EventTrader
Financial AI Models
PAPER
Menu
Dark Mode
Plain English Mode
PAPER TRADING MODE — Enable real trading on your Account page
Back
← All research reports Shareable version ↗

← Research reports

Quant Hedge-Fund Blowups vs. Tuatara (M&A Ripple)

2026 · Tuatara figures from the live /fund-performance index · external figures cited
Traders at a wall of market screens
Photo: Financial Times

The two events

#EventDate(s)What
AHedge funds' worst month vs S&P 500 in 20+ yearsJuly 2026 (full month) AI/semis de-gross. Rokos −1.2%, Brevan −1.2% (July).
BQuant hedge funds' worst day in two years2026-08-19 (turbulence 2026-08-18..21) Moderna +177% intraday 08-19 (melanoma vaccine) torched quant shorts; Treasury buyback doubling added bond havoc.

Tuatara — M&A Ripple index

+14.99%
inception → Aug-14 peak (115.0)
+3.77%
July 28→31 window
2026-08-18
last loaded close (113.6)
100live 2026-08-11100.0115.0113.6
Days before 2026-08-11 are the model index on real announced deals with paper execution; from 2026-08-11 on, live broker fills.

Side-by-side

Quant hedge fundsTuatara M&A Ripple Notes
July: worst month vs S&P in 20+ yrs (Rokos/Brevan −1.2%)+3.77%
2026-07-28 100.00 → 2026-07-31 103.77
paper (model index; live execution began 2026-08-11)
Aug 18–22: worst day in 2 yrs (08-19, Moderna +177%)n/a
no index point after 2026-08-18; 08-19..22 closes not yet loaded — does not yet reflect the 08-19 blowup day (last close 2026-08-18 = 113.57)
No returns are fabricated. Every Tuatara number is the live-chart index; the Aug close-data gap is disclosed, not filled.

Sources

Hedge funds' worst month vs S&P 500 in 20+ years

  • CNBC 2026-08-21 — Goldman: hedge funds' worst underperformance vs S&P 500 in July in 20+ years
  • Bloomberg 2026-08-19 — Rokos, Brevan Join Hedge Fund Peers Wrongfooted in July Havoc
  • Hedgeweek 2026-08-21 — Hedge funds suffer historic July setback as AI trade unravels

Quant hedge funds' worst day in two years

  • Financial Times 2026-08-20 — Quant hedge funds suffer worst day in 2 years as Treasury boosts buyback and Moderna shares leap (Pollard, Shah, Franklin)
  • Fortune 2026-08-19 — Moderna & Merck mRNA melanoma vaccine sends stocks soaring
  • TIKR 2026-08-19 — Moderna stock skyrockets 177% after positive late-stage skin cancer vaccine trial
  • WSWS 2026-08-21 — Bessent's bond market intervention falls flat